Intracranial Neoplasms and Paraneoplastic Disorders, Skull Base Tumor Syndromes
Adams & Victors Principles of Neurology, Chp 31, pg 672, Ropper, A.H.,et al, 2014
Hearing Improvement After Bevacizumab in Patients with Neurofibromatosis Type 2
NEJM 361:358-367, Plotkin,S.R.,et al, 2009
Neurofibromatosis Type 2
Lancet 373:1974-1986, Astagiri,A.R.,et al, 2009
Diagnostic Criteria for Schwannomatosis
Neurol 64:1838-1845, MacCollin,M.,et al, 2005